Angie Rantell ICS Chair
Roger Roman Dmochowski ICS Chair
Alan J Wein ICS Chair
#643 Do abnormal toileting behaviors contribute to worse urinary symptoms in women?
Kowalik C G1, Daily A1, Delpe S1, Kaufman M R1, Dmochowski R1, Reynolds W S11. Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA Female, Overactive Bladder, Questionnaire, Voiding Dysfunction
#644 Trends in the Utilization of Third Line Treatment Modalities for Overactive Bladder
Drangsholt S1, Slawin J1, Brucker B M11. New York University Neuromodulation, Overactive Bladder, Outcomes Research Methods
#645 The effectiveness of nurse-delivered Botulinum toxin-A injections with flexible cystoscopy under local anaesthetic to treat female idiopathic overactive bladder.
Smith G1, Bolderson J1, Lane S2, Trochez R11. Liverpool Women's Hospital NHS Trust, 2. University of Liverpool Female, Overactive Bladder, Urgency Urinary Incontinence
#646 A single procedure of Selective Bladder Denervation (SBD) of the trigone in patients with overactive bladder (OAB) appears to result in symptom improvement for 12 months
Rovner E1, Tu L2, De Wachter S G3, Versi E4, Dmochowski R51. Medical University of South Carolina, USA, 2. Sherbrooke University Hospital, Canada, 3. University of Antwerp, Belgium, 4. Rutgers Robert Wood Johnson Medical School, NJ, USA, 5. Vanderbilt University, USA Overactive Bladder, New Devices, Clinical Trial, Female, Sensory Dysfunction
#647 Understanding the relationship between anterior vaginal compartment prolapse and overactive bladder
Diez-Itza I1, Martín-Martínez A2, Uranga S1, Avila M1, Lekuona A1, García-Hernández J A21. Hospital Universitario Donostia. San Sebastian. Spain, 2. Complejo Hospitalario Universitario Insular Materno Infantil. Las Palmas de Gran Canaria. Spain Overactive Bladder, Pelvic Organ Prolapse, Anatomy
#648 Efficacy of tadalafil monotherapy and associations between changes in subjective overactive bladder symptoms and changes in oxidative stress in patients with lower urinary tract symptoms
Matsuo T1, Miyata Y1, Araki K1, Nakamura Y1, Sagara Y1, Ohba K1, Sakai H11. Nagasaki University Hospital Overactive Bladder, Prospective Study, Male, Gerontology
#649 Early and Consistent Improvements in Urinary Symptoms and Quality of Life in Idiopathic Overactive Bladder Patients Following Repeat Treatment With OnabotulinumtoxinA: Results of a Multicenter, Randomized, Placebo-Controlled, Phase 4 Trial
McCammon K1, Gousse A2, Gruenenfelder J3, Hale D4, Orejudos A5, Patel A6, Kohan A71. Eastern Virginia Medical School, Norfolk, VA, USA, 2. Memorial Hospital Miramar, Miramar, FL, USA, 3. Orange County Urology Associates, Laguna Hills, CA, USA, 4. Urogynecology Associates, PC, Indianapolis, IN, USA, 5. Allergan plc, Irvine, CA, USA, 6. Allergan plc, Marlow, UK, 7. Advanced Urology Centers of New York, Bethpage, NY, USA Incontinence, Overactive Bladder, Urgency/Frequency
#650 Is the ice water test associated with anticholinergic resistance in patients with idiopathic overactive bladder?
Waterschoot M1, Uvin P1, Everaerts W2, Raskin Y1, Voets T3, Van Oudenhove L4, Van der Aa F2, van den Heijkant M51. Department of Urology, University of Leuven, 2. Department of development and regeneration, organ systems, Experimental Urology, University of Leuven, 3. Laboratory of Ion Channel Research, Department of Cellular and Molecular Medicine, University of Leuven & VIB Center for Brain & Disease Research, Leuven, 4. Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical & Experimental Medicine, University of Leuven, Belgium & University Psychiatric Centre KU Leuven, Leuven, 5. Department of Urology, Department of pediatric Urology, University of KU Leuven Overactive Bladder, Detrusor Overactivity, Prospective Study, Urodynamics Techniques, Questionnaire
#651 Do overactive bladder symptoms exhibit a Gaussian distribution? Implications for reporting of clinical trial data
Amiri M1, Murgas S2, Michel M C31. University of Duisburg-Essen, 2. Apogepha, 3. Johannes Gutenberg University Overactive Bladder, Outcomes Research Methods, Prospective Study, Pharmacology, Incontinence
#652 Patients have poor compliance with repeat OnabotulinumtoxinA injections for overactive bladder
Nguyen A1, Tam J2, Du C1, Wang Q1, Hung M2, Kim J21. Stony Brook University School of Medicine, 2. Stony Brook University Medical Center Department of Urology Overactive Bladder, Detrusor Overactivity, Urgency/Frequency, Voiding Dysfunction , Retrospective Study
#653 OAB symptoms: Momentary digital assessment, a solution to unmet clinical needs, using a real life symptom evaluation.
Herrewegh A1, Vrijens D1, Kruimel J2, Leue C3, van Koeveringe G11. Maastricht University Medical Center+, Department of Urology, Pelvic Care Center, 2. Maastricht University Medical Center+, Division of Gastroenterology-Hepatology, Department of Internal Medicine, 3. Maastricht University Medical Center+, Department of Psychiatry and Medical Psychology Overactive Bladder, Questionnaire, Terminology, Quality of Life (QoL), Pathophysiology
#654 Evidence-based management of overactive bladder patients: Expectation to become symptom-free
Michel M C1, Murgas S2, Oelke M3, Schneider T41. Johannes Gutenberg University, 2. Apogepha, 3. St Antonius Hospital, 4. Praxis-Klinik Rhein-Ruhr Overactive Bladder, Outcomes Research Methods, Clinical Trial, Pharmacology